“…The etiology of cerebral infarction was classified as follows: (1) atherosclerosis, evidence of vascular risk factors and atheromatous lesions on Doppler and/or cerebral angiography related to clinical manifestations, (2) cardioembolism, presence of cardiac conditions associated with embolism with echocardiographic confirmation of embolic source [15]; the presence of patent foramen ovale (PFO) or MVP with myxomatous degeneration with no other potential cause of stroke was considered as a cause of cardioembolic cerebral infarction, (3) nonatherosclerotic vasculopathy, including spontaneous cervicocerebral arterial dissection [16], fibromuscular dysplasia [17], Takayasu's arteritis [18], parasitic arteritis (cysticercosis) [19], primary central nervous system arteritis [20], and drug-induced vasculopathy [21], (4) hematologic factors, including natural anticoagulant factor deficiencies [22], antiphospholipid antibodies (only considered as etiologic evidence in the absence of another cause of cerebral infarction) [23], hypercoagulable state related to pregnancy and puerperium [24], Sneddon's syndrome [25], and resistance to activated C protein [26], (5) migraine [14], and (6) cryptogenic factors, when based on the above criteria it was not possible to determine the etiology.…”